DEVELOPMENT OF CHRYSIN DRY POWDER INHALER FORMULATION FOR THE POTENTIAL TREATMENT OF RESPIRATORY-RELATED DISEASES

被引：0
|
作者：
Oum, Rahaf [1 ]
Al Ayoub, Yuosef [1 ]
Paradkar, A. [1 ]
Abu Abed, Omar [2 ]
Assi, K. H. [1 ]
机构：
[1] Univ Bradford, Sch Pharm & Med Sci, Bradford BD7 1DP, W Yorkshire, England
[2] Arab Amer Univ Palestine, Fac Grad Studies, Ramallah, Palestine
来源：
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY | 2021年 / 34卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
44
引用
收藏
页码：A15 / A15
页数：1
相关论文
共 50 条
  • [21] Cortical sources of the respiratory-related evoked potential
    von Leupoldt, Andreas
    Keil, Andreas
    Chan, Pei-Ying S.
    Bradley, Margaret M.
    Lang, Peter J.
    Davenport, Paul W.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2010, 170 (02) : 198 - 201
  • [22] Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
    S.Chennakesavulu
    A.Mishra
    A.Sudheer
    C.Sowmya
    C.Suryaprakash Reddy
    E.Bhargav
    AsianJournalofPharmaceuticalSciences, 2018, 13 (01) : 91 - 100
  • [23] Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
    Chennakesavulu, S.
    Mishra, A.
    Sudheer, A.
    Sowmya, C.
    Reddy, C. Suryaprakash
    Bhargav, E.
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 13 (01) : 91 - 100
  • [24] Respiratory-related evoked potential measures of respiratory sensory gating
    Chan, Pei-Ying Sarah
    Davenport, Paul W.
    JOURNAL OF APPLIED PHYSIOLOGY, 2008, 105 (04) : 1106 - 1113
  • [25] RESPIRATORY-RELATED EVOKED POTENTIALS IN CHILDREN WITH NEUROMUSCULAR DISEASES
    Nicot, F. J.
    Renault, F. R.
    Flores-Guevara, R. R.
    MUSCLE & NERVE, 2011, 44 (04) : 633 - 633
  • [26] Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery
    Rashid, Md Abdur
    Elgied, Amged Awad
    Alhamhoom, Yahya
    Chan, Enoch
    Rintoul, Llew
    Allahham, Ayman
    Islam, Nazrul
    PHARMACEUTICS, 2019, 11 (05):
  • [27] FORMULATION OPTIMIZATION AND PERFORMANCE OF THE MICRONIZER - A NOVEL ACTIVE DRY POWDER INHALER
    Wagenseil, L.
    Steckel, H.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2013, 26 (05) : A12 - A12
  • [28] Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler
    Salem, H. F.
    Abdelrahim, M. E.
    Eid, K. Abo
    Sharaf, M. A.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2011, 6 : 311 - 320
  • [29] FORMULATION OF DRY POWDER TOBRAMYCIN FOR THE TWINCER™ HIGH DOSE, DISPOSABLE INHALER
    Hoppentocht, M.
    Hagedoorn, P.
    Frijlink, H. W.
    de Boer, A. H.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2013, 26 (04) : A237 - A238
  • [30] Optimization of a dry powder inhaler formulation of nacystelyn, a new mucoactive agent
    Vanderbist, F
    Wery, B
    Moyano-Pavon, I
    Moës, AJ
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (11) : 1229 - 1234
12345